Osteoclast_NN
markers_NNS
accumulate_VBP
on_IN
cells_NNS
developing_VBG
from_IN
human_JJ
peripheral_JJ
blood_NN
mononuclear_JJ
precursors_NNS
._.

Recent_JJ
studies_NNS
show_VBP
that_IN
human_JJ
osteoclasts_NNS
develop_VBP
in_FW
vitro_FW
from_IN
hematopoietic_JJ
cells_NNS
;_:
however_RB
,_,
special_JJ
cultures_NNS
conditions_NNS
and\/or_CC
cytokine_NN
mobilized_VBN
peripheral_JJ
blood_NN
are_VBP
apparently_RB
required_VBN
._.

Here_RB
,_,
we_PRP
report_VBP
that_IN
cells_NNS
expressing_VBG
osteoclast_JJ
markers_NNS
differentiate_VBP
from_IN
precursors_NNS
present_JJ
in_IN
nonmobilized_JJ
peripheral_JJ
blood_NN
mononuclear_JJ
cells_NNS
-LRB-_-LRB-
PBMC_NN
-RRB-_-RRB-
,_,
without_IN
the_DT
addition_NN
of_IN
stromal_JJ
cells_NNS
,_,
growth_NN
factors_NNS
,_,
cytokines_NNS
or_CC
steroids_NNS
;_:
and_CC
characterize_VBP
their_PRP$
phenotype_NN
._.

Three_CD
days_NNS
after_IN
establishing_VBG
high-density_JJ
PBMC_NN
cultures_NNS
-LRB-_-LRB-
1.5_CD
x_CC
10_CD
6_CD
cells\/cm2_NNS
-RRB-_-RRB-
,_,
in_IN
serum-containing_JJ
medium_NN
,_,
small_JJ
adherent_JJ
colonies_NNS
of_IN
tartrate_JJ
resistant_JJ
acid_NN
phosphatase_NN
positive_JJ
-LRB-_-LRB-
TRAP_NN
+_NN
-RRB-_-RRB-
cells_NNS
emerge_VBP
,_,
amidst_IN
massive_JJ
monocyte_NN
cell_NN
death_NN
._.

These_DT
adherent_JJ
cells_NNS
have_VBP
an_DT
eccentrically_RB
placed_JJ
,_,
round_JJ
nucleus_NN
,_,
and_CC
express_VBP
low_JJ
levels_NNS
of_IN
TRAP_NN
and_CC
sodium_NN
fluoride-resistant-alpha-naphthyl-acetate-esterase_NN
-LRB-_-LRB-
NaF-R-NSE_NN
-RRB-_-RRB-
._.

Over_IN
the_DT
next_JJ
week_NN
,_,
this_DT
cell_NN
population_NN
accumulates_VBZ
phenotypic_JJ
markers_NNS
of_IN
osteoclasts_NNS
-LRB-_-LRB-
vitronectin_NN
receptor_NN
-LCB-_-LRB-
VR_NN
-RCB-_-RRB-
,_,
calcitonin_NN
receptor_NN
,_,
TRAP_NN
,_,
cathepsin_NN
K_NN
protein_NN
,_,
and_CC
mRNA_NN
-RRB-_-RRB-
with_IN
increased_VBN
nuclearity_NN
,_,
covering_VBG
the_DT
entire_JJ
surface_NN
by_IN
15_CD
days_NNS
._.

When_WRB
cultured_VBN
on_IN
bone_NN
,_,
VR_NN
+_JJ
,_,
TRAP_JJ
+_JJ
cells_NNS
of_IN
low_JJ
multinuclearity_NN
appear_VBP
and_CC
cover_VBP
up_RB
to_TO
50_CD
%_NN
of_IN
the_DT
surface_NN
._.

Resorption_NN
lacunae_NNS
can_MD
be_VB
observed_VBN
by_IN
day_NN
22_CD
._.

Although_IN
these_DT
pits_NNS
are_VBP
not_RB
nearly_RB
as_RB
numerous_JJ
as_IN
the_DT
cells_NNS
of_IN
preosteoclast_JJ
phenotype_NN
,_,
they_PRP
do_VBP
represent_VB
the_DT
activity_NN
of_IN
a_DT
subset_NN
of_IN
osteoclast-like_JJ
cells_NNS
that_WDT
has_VBZ
achieved_VBN
osteoclastic_JJ
maturity_NN
under_IN
these_DT
culture_NN
conditions_NNS
._.

Transcripts_NNS
for_IN
osteoprotegerin_NN
ligand_NN
-LRB-_-LRB-
OPGL_NN
-RRB-_-RRB-
,_,
an_DT
osteoclast_JJ
differentiation_NN
factor_NN
-LRB-_-LRB-
also_RB
known_VBN
as_IN
RANKL_NN
and_CC
TRANCE_NN
-RRB-_-RRB-
are_VBP
expressed_VBN
,_,
likely_RB
by_IN
adherent_JJ
cells_NNS
._.

Thus_RB
,_,
an_DT
adherent_JJ
population_NN
of_IN
cells_NNS
,_,
with_IN
preosteoclast\/osteoclast_JJ
phenotypic_JJ
properties_NNS
,_,
arises_VBZ
selectively_RB
under_IN
simple_JJ
culture_NN
conditions_NNS
from_IN
normal_JJ
PBMC_NNS
._.

Further_JJ
characterization_NN
of_IN
these_DT
cells_NNS
should_MD
identify_VB
factors_NNS
involved_VBN
in_IN
the_DT
growth_NN
,_,
terminal_JJ
differentiation_NN
and_CC
activation_NN
of_IN
osteoclasts_NNS
._.

